Related Experiment Video
Updated: Mar 20, 2026

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
The importance of systematic approaches in the study of emesis
Bart C De Jonghe1, Charles C Horn2
1University of Pennsylvania; School of Nursing; Department of Biobehavioral Health Sciences ; Philadelphia, PA USA.
Abstract:
Nausea and vomiting are among the most basic of human experiences and unfortunately accompany a wide variety of clinical treatments as side effects. Despite decades of research, the neural mechanisms of nausea and vomiting (emesis) remain elusive. TRPV1 represents a possibly overlooked and understudied pharmacological target with anti-emetic potential.
Insights
Nausea and vomiting (emesis) are common side effects of clinical treatments. Research suggests the TRPV1 receptor may be a potential target for anti-emetic drugs, offering new hope for managing these symptoms.
Area of Science:
- Neuroscience
- Pharmacology
- Gastroenterology
Background:
- Nausea and vomiting (emesis) are common and distressing human experiences.
- These symptoms frequently occur as side effects of various medical treatments.
- The precise neural mechanisms underlying emesis are not fully understood despite extensive research.
Purpose of the Study:
- To explore the potential of Transient Receptor Potential Vanilloid 1 (TRPV1) as a pharmacological target for anti-emetic therapies.
- To investigate the understudied role of TRPV1 in the neural pathways of nausea and vomiting.
Main Methods:
- This study reviews existing research on the neural pathways of emesis.
- It specifically examines the expression and function of TRPV1 in relevant neuronal circuits.
- Pharmacological data regarding TRPV1 modulation and its effects on emesis are analyzed.
Main Results:
- TRPV1 channels are expressed in key areas of the brainstem involved in emesis.
- Modulation of TRPV1 activity has shown promise in preclinical models for reducing nausea and vomiting.
- TRPV1 represents a potentially novel target for anti-emetic drug development.
Conclusions:
- The TRPV1 receptor is a promising, yet understudied, target for developing new anti-emetic treatments.
- Further research into TRPV1's role in emesis could lead to improved management of treatment-induced nausea and vomiting.
More Related Videos
06:18Assessing the Autonomic and Behavioral Effects of Passive Motion in Rats using Elevator Vertical Motion and Ferris-Wheel Rotation
Published on: February 7, 2020
05:33Author Spotlight: Alleviating Nausea and Vomiting in Pregnancy with Safe and Effective Auricular Acupuncture
Published on: August 4, 2023
Related Concept Videos
Pathophysiology of Vomiting
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Assessment of the Gastrointestinal System II: Health Perception Pattern
Health Perception Patterns
Health perception patterns offer valuable insights into a patient's lifestyle habits and how they may impact their GI health. These patterns include:
Physiology of the Gastrointestinal System III: Elimination
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
Prevention of Further Absorption of Poison